Sorry, you need to enable JavaScript to visit this website.

Rheumatoid Arthritis Treatment | SIMPONI® (golimumab)

WHAT YOU CAN EXPECT FROM YOUR SIMPONI® EXPERIENCE

For adults with moderate to severe RA:

  • Taken with the medicine methotrexate, as directed
  • Once you and your doctor are comfortable with the self-injection process, you will inject SIMPONI® under the skin, just once a month

Just One Injection, Once a Month

SIMPONI® is taken with the medicine methotrexate as directed. Keep in mind that, while how often you take a medicine matters, there are other important factors to consider. Talk to your doctor about treatment options and what might be right for you.

Your doctor will teach you how to self-inject SIMPONI® under the skin. Once you and your doctor are comfortable with the self-injection process, you will inject SIMPONI® under the skin, just once a month.

Fewer injections under the skin each month with SIMPONI®

Recommended monthly dosing for selected self-injectable anti-TNF biologic medications for adults with moderate to severe RA
Minimum number of injections every 4 weeks/month

SIMPONI®(golimumab)+ methotrexate

SIMPONI® (golimumab) + methotrexate Dose for moderate to severe rheumatoid arthritis

HUMIRA®*(adalimumab)

SIMPONI® (golimumab) + methotrexate Dose vs HUMIRA® (adalimumab) Dose for moderate to severe rheumatoid arthritis

ENBREL®*(etanercept)

SIMPONI® (golimumab) + methotrexate Dose vs ENBREL® (entanercept) Dose for moderate to severe rheumatoid arthritis

Humira® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. Humira® can be used alone or in combination with MTX or other non-biologic disease-modifying anti-rheumatic drugs (DMARDS).

Enbrel® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active RA. Enbrel® can be initiated in combination with MTX or used alone.

Prior TNF-alpha inhibitors used under the skin (subcutaneous injection) in a clinical study were Humira® and Enbrel®.

*Trademarks are the property of their respective owners.

This presentation is not intended to compare the safety, effectiveness, or uses of these treatments. This information, along with other factors, can be considered with your doctor when discussing treatment options. Please refer to each product's Prescribing Information and Medication Guide for recommended dosing and administration.

While dosing may be important, there are other factors to consider. So talk to your doctor about treatment options and what might be right for you.
 

Janssen CarePath Savings Program for SIMPONI®

Eligible patients using commercial insurance can save on out-of-pocket medication costs for SIMPONI®Eligible patients pay $5 per injection, with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. Program does not cover the cost to give you your injection.

See full eligibility requirements

Connect with us

Whether you are only considering a biologic or have already started treatment with SIMPONI®, connect with us to learn more.

Sign Up

connect